DrugPatentWatch Database Preview
Zenpep Company Profile
Email this page to a colleague
» See Plans and PricingUS Patents for Zenpep
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zenpep | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | 007 | 2009-08-27 | 8,562,981 | Aptalis Pharma Limited (Wicklow, IE) | 2027-02-20 | RX | company | |
| Zenpep | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | 007 | 2009-08-27 | 8,562,980 | Aptalis Pharma Limited (Wicklow, IE) | 2027-02-20 | RX | company | |
| Zenpep | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | 007 | 2009-08-27 | 8,562,979 | Aptalis Pharma Limited (Wicklow, IE) | 2027-02-20 | RX | company | |
| Zenpep | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | 007 | 2009-08-27 | 8,562,978 | Aptalis Pharma Limited (Wicklow, IE) | 2027-02-20 | RX | company | |
| Zenpep | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | 007 | 2009-08-27 | 8,293,229 | Aptalis Pharma Limited (Wicklow, IE) | 2027-02-20 | RX | company | |
| Zenpep | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210 | 007 | 2009-08-27 | 8,246,950 | Aptalis Pharma Limited (Wicklow, IE) | 2027-02-20 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
